US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 22.2700
  • +0.2200+1.00%
Close Mar 17 16:00 ET
  • 22.7900
  • +0.5200+2.33%
Pre 04:26 ET
243.93MMarket Cap-0.83P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-686.97%-176.53M
-131.21%-29.41M
-2,145.72%-36.7M
-3,777.53%-103.78M
39.03%-6.64M
21.22%-22.43M
39.42%-12.72M
-105.84%-1.63M
123.84%2.82M
53.84%-10.9M
Net income from continuing operations
-640.60%-169.83M
-1,527.98%-52.31M
-75.52%-15.99M
-569.47%-91.21M
-442.71%-10.33M
31.72%-22.93M
81.28%-3.21M
-160.80%-9.11M
-3.85%-13.62M
116.48%3.01M
Depreciation and amortization
97.46%233K
51.28%59K
177.27%61K
128.00%57K
75.00%56K
-17.48%118K
34.48%39K
-40.54%22K
111.36%25K
-89.23%32K
Other non cash items
148.95%3.09M
5.14%307K
11.90%301K
3,994.83%2.26M
-70.15%220K
26.27%1.24M
118.40%292K
-86.85%269K
-111.09%-58K
73,600.00%737K
Change In working capital
-255.43%-13.93M
295.59%20.87M
-441.73%-21.82M
-199.40%-15.59M
117.04%2.61M
-963.44%-3.92M
-261.08%-10.67M
-36.58%6.39M
5,093.38%15.68M
-120.02%-15.32M
-Change in receivables
237.09%14.28M
100.04%5K
-71.80%650K
-77.44%4.66M
144.19%8.97M
-2,083.02%-10.41M
-1,552.09%-13.07M
1,197.62%2.31M
422.35%20.64M
-492.00%-20.29M
-Change in inventory
200.00%6.1M
--0
--0
404.40%7.27M
---1.17M
---6.1M
---3.2M
---513K
---2.39M
--0
-Change in prepaid assets
-390.52%-10.85M
1,566.42%15.98M
-4,208.99%-26.96M
-68.87%396K
-132.19%-273K
253.07%3.74M
223.26%959K
-27.51%656K
187.91%1.27M
175.71%848K
-Change in payables and accrued expense
-54.50%7M
-14.19%5.18M
-26.63%3.37M
-44.37%731K
-165.83%-2.27M
877.89%15.39M
131.06%6.03M
928.88%4.59M
215.26%1.31M
425.57%3.45M
-Change in other current liabilities
-11.20%-1.08M
-58.33%-304K
-58.60%-295K
6.23%-286K
32.07%-197K
7.51%-973K
4.95%-192K
36.08%-186K
-7.77%-305K
-5.07%-290K
-Change in other working capital
-427.97%-29.38M
100.83%10K
400.85%1.41M
-485.00%-28.36M
-354.86%-2.44M
-295.30%-5.56M
68.22%-1.21M
-104.58%-468K
-522.21%-4.85M
134.22%957K
Cash from discontinued investing activities
Operating cash flow
-686.97%-176.53M
-131.21%-29.41M
-2,145.72%-36.7M
-3,777.53%-103.78M
39.03%-6.64M
21.22%-22.43M
39.42%-12.72M
-105.84%-1.63M
123.84%2.82M
53.84%-10.9M
Investing cash flow
Cash flow from continuing investing activities
74.46%-129K
0
15.87%-106K
0
75.53%-23K
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
Net PPE purchase and sale
74.46%-129K
--0
15.87%-106K
--0
75.53%-23K
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
Cash from discontinued investing activities
Investing cash flow
74.46%-129K
--0
15.87%-106K
--0
75.53%-23K
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
Financing cash flow
Cash flow from continuing financing activities
1,197.19%337.06M
1,227,462.50%98.21M
-182K
91,721.07%239.13M
-100.35%-93K
2,832.28%25.98M
-98.80%8K
0
76.51%-261K
4,394.11%26.24M
Net issuance payments of debt
---276K
---76K
---75K
---75K
---50K
--0
--0
--0
--0
--0
Net common stock issuance
1,199.27%337.33M
9,823,400.00%98.24M
---107K
91,748.28%239.2M
--0
999.20%25.96M
-99.85%1K
--0
---261K
5,144.60%26.22M
Proceeds from stock option exercised by employees
119.05%46K
557.14%46K
--0
--0
--0
--21K
--7K
--0
--0
--14K
Net other financing activities
---39K
--0
--0
--4K
---43K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,197.19%337.06M
1,227,462.50%98.21M
---182K
91,721.07%239.13M
-100.35%-93K
2,832.28%25.98M
-98.80%8K
--0
76.51%-261K
4,394.11%26.24M
Net cash flow
Beginning cash position
9.31%35.78M
161.73%127.39M
225.93%164.37M
-39.52%29.02M
9.31%35.78M
-47.44%32.73M
-8.30%48.67M
101.66%50.43M
26.35%47.98M
-47.44%32.73M
Current changes in cash
5,164.16%160.4M
633.59%68.79M
-2,001.31%-36.98M
5,415.53%135.35M
-144.34%-6.76M
110.31%3.05M
36.64%-12.89M
-106.27%-1.76M
118.93%2.45M
162.73%15.25M
End cash Position
448.32%196.18M
448.32%196.18M
161.73%127.39M
225.93%164.37M
-39.52%29.02M
9.31%35.78M
9.31%35.78M
-8.30%48.67M
101.66%50.43M
26.35%47.98M
Free cash flow
-670.21%-176.66M
-128.02%-29.41M
-1,990.97%-36.8M
-3,922.47%-103.78M
39.35%-6.67M
19.78%-22.94M
38.60%-12.9M
-106.29%-1.76M
122.91%2.72M
53.60%-10.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -686.97%-176.53M-131.21%-29.41M-2,145.72%-36.7M-3,777.53%-103.78M39.03%-6.64M21.22%-22.43M39.42%-12.72M-105.84%-1.63M123.84%2.82M53.84%-10.9M
Net income from continuing operations -640.60%-169.83M-1,527.98%-52.31M-75.52%-15.99M-569.47%-91.21M-442.71%-10.33M31.72%-22.93M81.28%-3.21M-160.80%-9.11M-3.85%-13.62M116.48%3.01M
Depreciation and amortization 97.46%233K51.28%59K177.27%61K128.00%57K75.00%56K-17.48%118K34.48%39K-40.54%22K111.36%25K-89.23%32K
Other non cash items 148.95%3.09M5.14%307K11.90%301K3,994.83%2.26M-70.15%220K26.27%1.24M118.40%292K-86.85%269K-111.09%-58K73,600.00%737K
Change In working capital -255.43%-13.93M295.59%20.87M-441.73%-21.82M-199.40%-15.59M117.04%2.61M-963.44%-3.92M-261.08%-10.67M-36.58%6.39M5,093.38%15.68M-120.02%-15.32M
-Change in receivables 237.09%14.28M100.04%5K-71.80%650K-77.44%4.66M144.19%8.97M-2,083.02%-10.41M-1,552.09%-13.07M1,197.62%2.31M422.35%20.64M-492.00%-20.29M
-Change in inventory 200.00%6.1M--0--0404.40%7.27M---1.17M---6.1M---3.2M---513K---2.39M--0
-Change in prepaid assets -390.52%-10.85M1,566.42%15.98M-4,208.99%-26.96M-68.87%396K-132.19%-273K253.07%3.74M223.26%959K-27.51%656K187.91%1.27M175.71%848K
-Change in payables and accrued expense -54.50%7M-14.19%5.18M-26.63%3.37M-44.37%731K-165.83%-2.27M877.89%15.39M131.06%6.03M928.88%4.59M215.26%1.31M425.57%3.45M
-Change in other current liabilities -11.20%-1.08M-58.33%-304K-58.60%-295K6.23%-286K32.07%-197K7.51%-973K4.95%-192K36.08%-186K-7.77%-305K-5.07%-290K
-Change in other working capital -427.97%-29.38M100.83%10K400.85%1.41M-485.00%-28.36M-354.86%-2.44M-295.30%-5.56M68.22%-1.21M-104.58%-468K-522.21%-4.85M134.22%957K
Cash from discontinued investing activities
Operating cash flow -686.97%-176.53M-131.21%-29.41M-2,145.72%-36.7M-3,777.53%-103.78M39.03%-6.64M21.22%-22.43M39.42%-12.72M-105.84%-1.63M123.84%2.82M53.84%-10.9M
Investing cash flow
Cash flow from continuing investing activities 74.46%-129K015.87%-106K075.53%-23K-327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K
Net PPE purchase and sale 74.46%-129K--015.87%-106K--075.53%-23K-327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K
Cash from discontinued investing activities
Investing cash flow 74.46%-129K--015.87%-106K--075.53%-23K-327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K
Financing cash flow
Cash flow from continuing financing activities 1,197.19%337.06M1,227,462.50%98.21M-182K91,721.07%239.13M-100.35%-93K2,832.28%25.98M-98.80%8K076.51%-261K4,394.11%26.24M
Net issuance payments of debt ---276K---76K---75K---75K---50K--0--0--0--0--0
Net common stock issuance 1,199.27%337.33M9,823,400.00%98.24M---107K91,748.28%239.2M--0999.20%25.96M-99.85%1K--0---261K5,144.60%26.22M
Proceeds from stock option exercised by employees 119.05%46K557.14%46K--0--0--0--21K--7K--0--0--14K
Net other financing activities ---39K--0--0--4K---43K--------------------
Cash from discontinued financing activities
Financing cash flow 1,197.19%337.06M1,227,462.50%98.21M---182K91,721.07%239.13M-100.35%-93K2,832.28%25.98M-98.80%8K--076.51%-261K4,394.11%26.24M
Net cash flow
Beginning cash position 9.31%35.78M161.73%127.39M225.93%164.37M-39.52%29.02M9.31%35.78M-47.44%32.73M-8.30%48.67M101.66%50.43M26.35%47.98M-47.44%32.73M
Current changes in cash 5,164.16%160.4M633.59%68.79M-2,001.31%-36.98M5,415.53%135.35M-144.34%-6.76M110.31%3.05M36.64%-12.89M-106.27%-1.76M118.93%2.45M162.73%15.25M
End cash Position 448.32%196.18M448.32%196.18M161.73%127.39M225.93%164.37M-39.52%29.02M9.31%35.78M9.31%35.78M-8.30%48.67M101.66%50.43M26.35%47.98M
Free cash flow -670.21%-176.66M-128.02%-29.41M-1,990.97%-36.8M-3,922.47%-103.78M39.35%-6.67M19.78%-22.94M38.60%-12.9M-106.29%-1.76M122.91%2.72M53.60%-10.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
New Fortress Energy
NFE
9.990
YETI Holdings
YETI
34.000
eBay
EBAY
67.440
4
Teradata Corp
TDC
23.290
5
Workday
WDAY
250.620
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!